R&D in Germany
Roche R&D in Germany conducts research in areas of significant unmet medical need. We develop new, efficient pharmaceuticals and tests for reliable diagnosis as an essential prerequisite for appropriate medical treatment. In doing so, we focus on 'patient stratification', where specific patient groups within the patient population are reliably matched to the right pharmaceuticals, as well as on the monitoring of treatment and of the effectiveness of pharmaceuticals over the duration of the treatment period.
The concept of companion diagnostics is important to Roche's pursuit of personalized healthcare – in this approach, tests that place patients in the correct patient group prior to treatment are developed in parallel with new pharmaceuticals.